Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content

Table 1 Expermimental design

From: Evaluation of the duration of new nasal drug interferon α-2b activity in an experimental model system

Group, №

Test drug "Spray" or "Gel"

Time after administration of nasal IFN into the nasal cavity of the rat / WNC

Number of animals

1.1

"Spray"

1 h

5

1.2

"Spray"

3 h

5

1.3

"Spray"

4 h

5

2.1

"Gel"

1 h

5

2.2

"Gel"

3 h

5

2.3

"Gel"

4 h

5

3.1

Control*

1 h

3

3.2

Control*

3 h

3

3.3

Control*

4 h

3

  1. *- physiological solution